Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.

Bone Marrow Transplantation
Paul J ShaughnessyS Abhyankar

Abstract

GVHD is partly mediated by host APCs that activate donor T cells. Extracorporeal photopheresis (ECP) can modulate APC function and benefit some patients with GVHD. We report the results of a study using ECP administered before a standard myeloablative preparative regimen intended to prevent GVHD. Grades II-IV acute GVHD developed in 9 (30%) of 30 recipients of HLA-matched related transplants and 13 (41%) of 32 recipients of HLA-matched unrelated or HLA-mismatched related donor transplants. Actuarial estimates of overall survival (OS) at day 100 and 1-year post transplant were 89% (95% CI, 78-94%) and 77% (95% CI, 64-86%), respectively. There were no unexpected adverse effects of ECP. Historical controls receiving similar conditioning and GVHD prophylaxis regimens but no ECP were identified from the database of the Center for International Blood and Marrow Transplant Research and multivariate analysis indicated a lower risk of grades II-IV acute GVHD in patients receiving ECP (P=0.04). Adjusted OS at 1 year was 83% in the ECP study group and 67% in the historical control group (relative risk 0.44; 95% CI, 0.24-0.80) (P=0.007). These preliminary data may indicate a potential survival advantage with ECP for transplant recipients u...Continue Reading

References

Mar 7, 1991·The New England Journal of Medicine·J L Ferrara, H J Deeg
Aug 1, 1980·The American Journal of Medicine·H M ShulmanE D Thomas
Sep 1, 1994·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·G I FegerM Wahl
Feb 9, 2000·The Journal of Experimental Medicine·R M SteinmanK Inaba
Mar 22, 2000·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·R N BarkerA J Rees
Apr 28, 2000·Leukemia & Lymphoma·H T GreinixR M Knobler
Jan 10, 2002·The Journal of Clinical Investigation·Mai-Lan N HuynhPeter M Henson
Aug 8, 2002·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·R Dall'Amico, C Messina
Aug 13, 2002·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Margaret L MacMillanBruce R Blazar
Mar 26, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Geoffrey W ChanFrancine M Foss
Aug 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mark LucasAdam Lacy-Hulbert
Apr 28, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Paul J MartinRainer Storb
May 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Akira MaedaThomas Schwarz
Jan 18, 2006·Seminars in Hematology·Nelson J Chao, Benny J Chen
Apr 28, 2006·The New England Journal of Medicine·Edward A Copelan

❮ Previous
Next ❯

Citations

Dec 7, 2013·Best Practice & Research. Clinical Haematology·Anthony D Sung, Nelson J Chao
Sep 14, 2011·Current Opinion in Hematology·Lia PerezJoseph Pidala
Jan 4, 2013·Stem Cells Translational Medicine·Anthony D Sung, Nelson J Chao
Jul 10, 2012·Expert Opinion on Pharmacotherapy·Andrew R Rezvani, Rainer F Storb
Nov 30, 2011·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Panayotis Kaloyannidis, Despina Mallouri
Apr 7, 2011·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·M Michallet
Mar 10, 2015·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Carrie L Kitko, John E Levine
Aug 12, 2015·Current Opinion in Organ Transplantation·Robin VosGeert M Verleden
Jan 11, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Christian M CapitiniTerry J Fry
Apr 26, 2015·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Cesare Perotti, Irena Sniecinski
May 2, 2014·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Hildegard T GreinixRobert Knobler
Sep 25, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Dong Hwan KimHans A Messner
Dec 21, 2013·Journal of the European Academy of Dermatology and Venereology : JEADV·R KnoblerU Hillen
Mar 18, 2011·Dermatologic Therapy·Rahul Chavan, Rokea el-Azhary
Oct 8, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·R KnoblerH Greinix
Nov 22, 2020·Bone Marrow Transplantation·Haitham AbdelhakimSunil Abhyankar
Jul 1, 2020·Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie·Beatrice DrexlerAndreas Holbro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

© 2022 Meta ULC. All rights reserved